Children with mild asthma at low risk for severe exacerbations may not need daily or as-needed ICS, as GINA guidelines recommend.
Find out about this new study that suggest that the lung scarring that severe asthma can cause could be reversible.
APG808 resulted in a rapid and durable decrease from baseline in FeNO and pSTAT6 measurements throughout the 12 weeks.
The FDA approved remibrutinib, the first oral treatment for adults with persistent chronic spontaneous urticaria despite H1 ...
The report updates the AAP’s 2010 guidance and emphasizes a proactive role for pediatricians in collaborating to manage ...
In various reports published in the year 2024, it was mentioned that out of the total deaths due to asthma in the world, the ...
Rhapsido helps to inhibit release of histamine and proinflammatory mediators by targeting BTK, offering unique approach to CSU treatment 1 Well-controlled ...
The FDA has cleared remibrutinib under the Rhapsido trade name as the first oral alternative to current injectable treatments ...
Christopher Carlin, MBChB, PhD, explores the potential of AI-driven insights to enhance COPD care and identify candidates for biologic therapy.
A new way to treat asthma symptoms and even repair previously irreversible lung damage could be on the horizon following the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback